1Alderman MH. A new model of risk: Implication of increasing pulse pressure and systolic blood pressure on cardiovascular disease[J] .J Hypertens, 1999,17(suppl 5) :S25 - S28.
2Lderman MH.Distribution and determinants of cardiovascular events during 20 years of successful antihypertensive treatment[J].J hypertens, 1998,16:761 - 769.
3Menotti A, Puddu PE, Lanti M.Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study[ J ]. European Heart Journal, 2000, 21 ( 5 ) :365 - 370.
4Stanley S, Franklin MD, Shehzad A, et al. Is pulse pressure useful in predicting risk for coronary heart diseas? The Framingham Heart Study[J ]. Circulation, 1999,100:354 - 360.
5O' rourke M, Frohlich ED. Pulse pressure is this a clinically useful risk factor[J]? Hypertension, 1999,34:372 - 374.
6Celermajer DS, Sorensen KE, Gooch VM, et al. Non - invasive detection of endothlial dysfunction in children and adults of atherosclerosis. Lancet, 1992; 340:1111 ～ 1115
8Panza JA, Casino PR, Kilcoyne CM, et al. Role of endothelium - derived nitiric oxide in the abnormal endthelium - dependent vascular relaxation of patients with essential hypertension. Circulation, 1993;87:1468 ～ 1474
9ToddJA, Akimi U, MarieD, et al. Close relationofendothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol, 1995; 26:1235 ～ 1241
10Kaeko Iiyama, Mashiro Nagano, Yoshikage YO. Impaired endothelial function with essential hypertension assessed by ultrasonography. Am Heart J, 1996; 132:179 ～ 182
